Pertega-Gomes, Nelma <br/><br/>
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.  [electronic resource] 

 -  The Journal of pathology  Aug 2015 
 - 517-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9896 
<br/><br/><label>Standard No.: </label>10.1002/path.4547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Disease Progression<br/>Drug Design<br/>Gene Expression Regulation, Neoplastic<br/>Glycolysis<br/>Humans<br/>Lactic Acid--metabolism<br/>Male<br/>Mice, Transgenic<br/>Molecular Targeted Therapy<br/>Monocarboxylic Acid Transporters--antagonists & inhibitors<br/>Neoplasm Staging<br/>Phenotype<br/>Prostatic Neoplasms--drug therapy<br/>RNA Interference<br/>Time Factors<br/>Transfection<br/>Tumor Burden